- Indonesia
- Malaysia
- Singapore
- Thailand
- Vietnam
Quotient and Transmedic sign distribution agreement in Southeast Asia
Quotient and Transmedic have signed a distribution agreement, which will enable Transmedic to distribute Alba by Quotient® and MosaiQ™ in five countries in Southeast Asia.This significant partnership reaffirms Quotient’s commitment to grow and expand its geographical presence. It will enable both parties to introduce new quality services to the healthcare industry in Southeast Asia and enhance patient care.With a history spanning over four decades, Transmedic is a leader in medical technology. Headquartered in Singapore, the company operates in Southeast Asia. It is active in the distribution of medical devices and specialized drugs, education, and post-sales support.The distribution agreement takes effect immediately and will cover the following five countries in Southeast Asia:
Trending Topics
Our passion for the work we do is matched only by our commitment to consistently provide the best customer experience possible.
-
AliveDx Suisse S.A. and Lavichem Joint Stock Company Sign Distribution Agreement in North Vietnam
AliveDx Suisse S.A. and Lavichem Joint Stock Company have signed a distribution agreement, which will enable Lavichem to distribute the MosaiQ® solution in North Vietnam. The distribution agreement takes effect immediately. AliveDx is committed to broadening its reach and presence
-
AliveDx Suisse S.A. and Medlinks Consulting Joint Stock Company Sign Distribution Agreement in Vietnam
AliveDx Suisse S.A. and Medlinks Consulting Joint Stock Company have signed a distribution agreement, which will enable Medlinks to distribute the MosaiQ® solution in South Vietnam. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach and
-
Abstract Accepted by the European Congress of Immunology (ECI 2024)
We are excited to announce that our abstract titled “Performance characteristics of a novel, fully automated immunoassay microarray for the qualitative serological detection of specific IgE directed against Bet v 1” has been accepted by the European Congress of Immunology
-
AliveDx Suisse S.A. and Patho Solutions Malaysia Sdn. Bhd. sign Distribution Agreement in Malaysia
AliveDx Suisse S.A. and Patho Solutions Malaysia Sdn. Bhd. have signed a distribution agreement, which will enable Patho Solutions Malaysia to distribute the MosaiQ® solution in Malaysia. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach
-
AliveDx Suisse S.A. and Everlight Biotech Co Ltd. Sign Distribution Agreement in Taiwan
AliveDx Suisse S.A. and Everlight Biotech Co. Ltd. have signed a distribution agreement, which will enable Everlight Biotech Co. Ltd. to distribute the MosaiQ® solution in Taiwan. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach
-
Presenting the AliveDx 2023 Sustainability Report
At AliveDx, we understand that the success of our business is closely linked to the wellbeing of the communities in which we operate. Our goal is to advance sustainable practices in every aspect of our operations. We are pleased to
